OLK Live signals | Maximize Profits with Getagraph.com

BUY 93516 min ago

@ $24.62

Issued: 14 Feb 2024 @ 14:47

Return: -10.30%

Previous signal: Feb 13 - 15:46

Previous signal: Sell

Return: 0.59 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 14:23):

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research...

Stats
Today's Volume	353 530
Average Volume	644 696
Market Cap	2.75B
EPS	$-0.0600 ( 2024-03-26 )
Next earnings date	( $-0.120 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-88.32
ATR14	$0.00700 (0.03%)

Volume Correlation

Long: 0.17 (neutral)

Short: 0.73 (moderate)

Signal:(75.378) Neutral

Olink Holding AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Olink Holding AB (publ) Correlation - Currency/Commodity

0.45
( neutral )

0.39
( neutral )

0.00
( neutral )

0.25
( neutral )

-0.53
( weak negative )

0.00
( neutral )

Olink Holding AB (publ) Financials

Annual	2023
Revenue:	$169.91M
Gross Profit:	$98.87M (58.19 %)
EPS:	$-0.260

Q4	2023
Revenue:	$69.27M
Gross Profit:	$49.18M (71.00 %)
EPS:	$-0.0613

Q3	2023
Revenue:	$44.15M
Gross Profit:	$30.89M (69.96 %)
EPS:	$-0.0146

Q2	2023
Revenue:	$29.44M
Gross Profit:	$17.29M (58.74 %)
EPS:	$-0.0665

Financial Reports:

No articles found.

Olink Holding AB (publ)

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, it provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of NPX data. Olink Holding AB (publ) sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.